10.1002/ejoc.202001198
European Journal of Organic Chemistry
FULL PAPER
3251-3256; d) F. Zarrad, B. Zlatopolskiy, P. Krapf P, J. Zischler, B.
Neumaier, Molecules, 2017, 22:2231.
with stirring under inert atmosphere (N2 gas). The solvent was
evaporated by heating to 50 °C with stirring and the reaction
vessel was cooled down to 40 °C. To the dried residue the mixture
of 6 N HCl (0.4 mL), MeOH (0.3 mL) and 0.25 M ascorbic aсid
(0.2 mL) was added and hydrolysis was carried out for 5 min at
110 °C without stirring. The completeness of hydrolysis was
monitored by analysis of the hydrolysate aliquot using radioHPLC,
System 2. The liquids were evaporated by heating to 120 °C
under nitrogen flow with stirring. After cooling the reaction vessel
to 50 °C, 1.8 mL of HPLC mobile phase (0.1% acetic acid) was
added. The resulting solution (total volume about 1.8-1.9 mL) was
loaded onto the HPLC loop (2 mL) and injected into semi
preparative HPLC column Ascentis RP-AMIDE, 5 µm, 250×10
mm (Supelco). The semi preparative column was equipped with
a guard column to remove residual copper: Security Guard
Cartridge AJO-8327-S in Guard Cartridge Holder KJO-4282
(Phenomenex). The column outlet was connected to an UV
absorbance detector (λ=254 nm) in series with a radioactivity
detector (module TRACERlab FX C Pro (GE Healthcare). After
running HPLC with pure water (0-6 min) the mobile phase was
changed to 0.1% CH3COOH at a flow rate of 4 mL/min giving a
radioactive fraction (4-5 mL volume) corresponding to pure 6-L-
[18F]FDOPA (Rt from 12 to 13 min). The product fraction with pH
4 was collected into a vented sterile vial pre-filled with 5 mL of
sterile normal saline through the 0.22 μm Millipore filter.
[6]
a) D. Schäfer, P. Weiß, J. Ermert, J. C. Meleán, F. Zarrad, B. Neumaier,
Eur. J. Org. Chem., 2016, 27, 4621-4628; b) B. C. Giglio, H. Fei, M. Wang,
H. Wang, L. He, H. Feng, Z. Wu, H. Lu, Z. Li, Theranostics, 2017, 7,
1524-1530; c) B. D. Zlatopolskiy, J. Zischler, D. Schäfer, E. A. Urusova,
M. Guliyev, O. Bannykh, H. Endepols, B. Neumaier, J. Med. Chem.,
2018, 61, 189-206; d) V.V. Orlovskaya, A.S. Craig, R.N. Krasikova, O.S.
Fedorova, O.F. Kuznetsova, B. Neumaier, B.D. Zlatopolskiy, EJNMMI
Radiopharmacy and Chemistry, 2018, 3, 7; e) A.V. Mossine, S.S. Tanzey,
A.F. Brooks, K.J. Makaravage, N. Ichiishi, J.M. Miller, B.D. Henderson,
M.B. Skaddan, M.S. Sanford, P.J.H. Scott, Org. Biomol. Chem., 2019,
Neurosci., 2020, 11, 12, 1756-1761; g) B. D. Zlatopolskiy, F. Neumaier,
T. Rüngeler, B. Drewes, N. Kolks, B. Neumaier, Molecules, 2020, 25,
2880; doi:10.3390/molecules25122880.
[7]
[8]
a) S. Preshlock, S. Calderwood, S. Verhoog, M. Tredwell, M. Huiban, A.
Hienzsch, S. Gruber, T. C. Wilson, N. J. Taylor, T. Cailly, M. Schdler, T.
L. Collier, J. Passchier, R. Smits, J. Mollitor, A. Hoepping, M. Mueller, C.
Genicot, J. Mercier, V. Gouverneur, Chem. Commun., 2016, 52, 8361-
8364.
a) V. T. Lien, J. Klaveness, D. E. Olberg, J. Label Compd. Radioharm.,
2017, 61, 11-17; b) G.S. Clemente, T. Zarganes-Tzitzikas, A. Dumling,
P.H. Elsinga, Molecules, 2019, 24, 4210-4218; c) Wilson TC, Xavier MA,
Knight J, Verhoog S, Torres JB, Mosley M, Hopkins SL, Wallington S,
Allen PD, Kersemans V, Hueting R, Smart S, Gouverneur V, Cornelissen
B, J. Nucl. Med., 2019, 60, 504-510; d) V. Bernard-Gauthier, A. V.
Mossine, A. Mahringer, A. Aliaga, J.J. Bailey, X. Shao, J. Stauff, J.
Arteaga, P. Sherman, M. Grand Maison, P.L. Rochon, B. Wꢀngler, C.
Wꢀngler, P. Bartenstein, A. Kostikov, D. R. Kaplan, G. Fricker, P. Rosa-
Neto, P.J. H. Scott, R. Schirrmacher, J. Med. Chem., 2018, 61, 17370-
743; e) F. Guibbal, P.G. Isenegger, T.C. Wilson, A. Pacelli, D. Mahaut,
J.B.I. Sap, N.J. Taylor, S. Verhoog, S. Preshlock, R. Hueting,
B.Cornelissen, V. Gouverneur. Nat. Protoc., 2020, 15, 1525-1541; f) F.
Guibbal, V. Meneyrol, I. Ait-Arsa, N. Diotel, J. Patché, B. Veeren, S.
Bénard, F. Gimié, J. Yong-Sang, I. Khantalin, R. Veerapen, E. Jestin, O.
Meilhac, ACS Med. Chem. Lett., 2019, 10, 5, 743–748.
Acknowledgements
This study was supported by the state funding at the N.P.
Bechtereva Institute of Human Brain, Russian Academy of
Sciences. The authors thank Dr. Chuan-Lin Cheng (National
Yang-Ming University, Taipei, Taiwan) for providing precursor and
standard for protected 4-[18F]fluoro-L-phenylalanine.
[9]
B. D. Zlatopolskiy, J. Zischler, P. Krapf, F. Zarrad, E. A. Urusova, E.
Kordys, H. Endepols, B. Neumaier, Chem. A Eur. J., 2015, 21, 5972-
5979.
Keywords: Radiopharmaceuticals • Arenes • Copper mediated
radiofluorination • Pinacol esters • 6-L-[18F]FDOPA
[10]
a) A. V. Mossine, A. F. Brooks, N. Ichiishi, K. J. Makaravage, M. S.
Sanford, P. J. H. Scott, Sci. Reports, 2017, 7, 223; b) D. Antuganov, M.
Zykov, V. Timofeev, K. Timofeeva, Y. Antuganova, V. Orlovskaya, O.
Fedorova, R. Krasikova, Eur. J. Org. Chem., 2019, 918-922; c) Y. Zhang,
F. Basuli, R. E. Swenson, J. Labelled Compd. Radiopharm., 2019, 62,
139-145.
[1]
a) L. Cai, S. Lu, V.W. Pike, Eur. J. Org. Chem., 2008, 2853-2873; b) H.H.
Coenen, P.H. Elsinga, R. Iwata, M.R. Kilbourn, M.R. Pillai, M.G. Rajan,
H.N. Wagner, J.J. Zakhun, Nucl. Med. Biol., 2010, 37, 727-740; c) H. H.
Coenen, J. Ermert, Clin. Transl. Imaging, 2018, 6(3), 169-193.
a) S. Preshlock, M. Tredwell, V. Gouverneur, Chem. Rev., 2016, 116(2),
719-766; b) A.F. Brooks, J.J. Topczewsky, N. Ichishi, N., M.S. Sanford,
P.J.H. Scott, Chemical Science, 2014, 5, 4545-4553.; c) X. Deng, J.
Rong, L. Wang, N. Vasdev, L. Zhang, L. Josephson, S. Liang, Angew.
Chem. Int. Ed. 2019, 58, 2580-2605; d) J. S. Wright, T. Kaur, S.
Preshlock, S.S. Tanzey, W.P. Winton, L.S. Sharninghausen, N. Wiesner,
A.F. Brooks, M.S. Sanford, P.J. H. Scott, Clin. Transl. Imaging, 2020,
8, 167-206.
[11]
[12]
T. Zarganes-Tzitzikas, G.S. Clemente, P.H. Elsinga, A. Dömling,
Molecules, 2019, 24, 1327
[2]
a) A. V. Mossine, A. F. Brooks, V. Bernard-Gauthier, J. J. Bailey, N.
Ichiishi, R. Schirrmacher, M. S. Sanford, P. J. H. Scott, J. Labelled
Compd. Radiopharm., 2018, 61, 228-236; b) G. Yuan, T.M. Shoup, S-H.
Moon, A-L. Brownell, RSC Adv., 2020, 10, 25223-25227.
[13] N. J. Taylor, E. Emer, S. Preshlock, M. Schedler, M. Tredwell, S. Verhoog,
J. Mercier, C. Genicot, V. Gouverneur, J. Am. Chem. Soc., 2017, 139(24),
8267-8276.
[14]
[15]
[16]
[17]
V. Orlovskaya, D. Antuganov, O. Fedorova, V. Timofeev, R. Krasikova,
Appl. Rad. Isot., 2020, 163, 109195 (2020).
D. Taïeb, A. Imperiale, K. Pacak, Eur J Nucl Med Mol Imaging, 2016,
43, 1187-1189.
[3]
a) M. Tredwell, S. M. Preshlock, N. J. Taylor, S. Gruber, M. Huiban, J.
Passchier, J. Mercier, C. Génicot, V. Gouverneur, Angew. Chem. Int. Ed.,
2014, 53, 7751-7755; Angew. Chem., 2014, 126, 7885-7889; b) Y. Ye,
S. D. Schimler, P. S. Hanley, M. S. Sanford, J. Am. Chem. Soc., 2013,
135, 16292-16295.
M. Pretze, C. Wängler, B. Wängler, Biomed. Res. Int., 2014, article
674063. 2.
[4]
[5]
J.X. Qiao, P.Y.S. Lam, Synthesis, 2011, 6, 829-856.
ICH Guideline of Elemental Impurities Q3D.
a) A. V. Mossine, A. F. Brooks, K. J. Makaravage, J. M. Miller, N. Ichiishi,
M. S. Sanford, P. J. H. Scott, Org. Lett.Org. Lett., 2015, 17, 5780-5783;
b) K.J. Makaravage, A.F. Brooks, A.V. Mossine, M.S. Sanford, P.J.H.
Scott. Org. Lett., 2016, 18, 5440–5443; c) J. Zischler, N. Kolks, D.
Modemann, B. Neumaier, B. D. Zlatopolskiy, Chem. Eur. J., 2017, 23(14),
8
This article is protected by copyright. All rights reserved.